Inventor · disambiguated record
Garry Robert Smith
Also filed as: SMITH GARRY · SMITH GARRY R · SMITH GARRY ROBERT
42 granted patents·10 pending applications·329 citations·filing 1992–2025
98Inventor score
Files withBIOHAVEN THERAPEUTICS LTD11BIOHAVEN PHARM HOLDING CO LTD9WISTAR INST8MERCK & CO INC6PROMENTIS PHARM INC6
Top patents by PatentIndex Score
52 records- 0197US11052070B2Riluzole prodrugs and their useBIOHAVEN THERAPEUTICS LTD·Filed 2019·Granted Jul 6, 2021·9 cites·3 claims
- 0297US10639298B2Prodrugs of riluzole and their method of useBIOHAVEN PHARM HOLDING CO LTD·Filed 2016·Granted May 5, 2020·12 cites·10 claims
- 0397US10485791B2Riluzole prodrugs and their useBIOHAVEN PHARM HOLDING CO LTD·Filed 2016·Granted Nov 26, 2019·18 cites·4 claims
- 0496US12005047B2Riluzole prodrugs and their useBIOHAVEN THERAPEUTICS LTD·Filed 2023·Granted Jun 11, 2024·2 cites·6 claims
- 0596US10905681B2Riluzole prodrugs and their useBIOHAVEN THERAPEUTICS LTD·Filed 2019·Granted Feb 2, 2021·15 cites·11 claims
- 0696US6048861AIntegrin receptor antagonistsMERCK & CO INC·Filed 1998·Granted Apr 11, 2000·100 cites·47 claims
- 0795US10357497B2Pro-drugs of riluzole and their method of use for the treatment of amyotrophic lateral sclerosisBIOHAVEN PHARM HOLDING CO LTD·Filed 2013·Granted Jul 23, 2019·12 cites·4 claims
- 0895US9725427B2Prodrugs of riluzole and their method of useBIOHAVEN PHARM HOLDING CO LTD·Filed 2013·Granted Aug 8, 2017·20 cites·11 claims
- 0992US11440893B2Prodrugs of riluzole and their method of useBIOHAVEN PHARM HOLDING CO LTD·Filed 2020·Granted Sep 13, 2022·2 cites·5 claims
- 1092US11242317B2EBNA1 inhibitors and their method of useWISTAR INST·Filed 2019·Granted Feb 8, 2022·4 cites·17 claims
- 1191US11911369B2Prodrugs of riluzole and their method of useBIOHAVEN THERAPEUTICS LTD·Filed 2020·Granted Feb 27, 2024·2 cites·9 claims
- 1291US10981867B2EBNA1 inhibitors and methods using sameWISTAR INST·Filed 2019·Granted Apr 20, 2021·3 cites·13 claims
- 1391US10442763B2EBNA1 inhibitors and methods using sameWISTAR INST·Filed 2016·Granted Oct 15, 2019·4 cites·5 claims
- 1490US11197864B2Pro-drugs of riluzole and their method of use for the treatment of amyotrophic lateral sclerosisBIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD B·Filed 2019·Granted Dec 14, 2021·4 cites·8 claims
- 1590US10844026B2Prodrugs of riluzole and their method of useBIOHAVEN PHARM HOLDING CO LTD·Filed 2020·Granted Nov 24, 2020·2 cites·7 claims
- 1689US12472165B2Riluzole prodrugs and their useBIOHAVEN THERAPEUTICS LTD·Filed 2023·Granted Nov 18, 2025·0 cites·4 claims
- 1789US10961187B2Substituted N-acetyl-L-cysteine derivatives and related compoundsPROMENTIS PHARM INC·Filed 2019·Granted Mar 30, 2021·1 cites·24 claims
- 1889US2024059649A1Substituted n-acetyl-l-cysteine derivatives and related compoundsPROMENTIS PHARM INC·Filed 2023·Application pending·0 cites
- 1988US10562870B2Prodrugs of riluzole and their method of useBIOHAVEN PHARM HOLDING CO LTD·Filed 2017·Granted Feb 18, 2020·2 cites·3 claims
- 2088US6784190B2Integrin receptor antagonistsMERCK & CO INC·Filed 2001·Granted Aug 31, 2004·17 cites·23 claims
- 2186US9630937B2Substituted N-acetyl-L-cysteine derivatives and related compoundsPROMENTIS PHARM INC·Filed 2014·Granted Apr 25, 2017·5 cites·60 claims
- 2285US10358414B2Substituted N-acetyl-L-cysteine derivatives and related compoundsPROMENTIS PHARM INC·Filed 2017·Granted Jul 23, 2019·3 cites·21 claims
- 2384US2024246909A1EBNA1 Inhibitors and Methods Using SameWISTAR INST·Filed 2024·Application pending·0 cites
- 2482US12172974B2Prodrugs of riluzole and their method of useBIOHAVEN PHARM HOLDING CO LTD·Filed 2022·Granted Dec 24, 2024·0 cites·8 claims
- 2581US6413955B1Integrin receptor antagonistsMERCK & CO INC·Filed 2000·Granted Jul 2, 2002·17 cites·21 claims
- 2679US12213965B2Riluzole prodrugs and their useBIOHAVEN THERAPEUTICS LTD·Filed 2021·Granted Feb 4, 2025·0 cites·5 claims
- 2778US12005046B2Riluzole prodrugs and their useBIOHAVEN THERAPEUTICS LTD·Filed 2021·Granted Jun 11, 2024·0 cites·8 claims
- 2878US2021395194A1Substituted n-acetyl-l-cysteine derivatives and related compoundsPROMENTIS PHARM INC·Filed 2021·Application pending·0 cites
- 2977US12258314B2EBNA1 inhibitors and their method of useWISTAR INST·Filed 2021·Granted Mar 25, 2025·0 cites·7 claims
- 3076US12343347B2Pro-drugs of riluzole and their method of use for the treatment of amyotrophic lateral sclerosisBIOHAVEN PHARM HOLDING CO LTD·Filed 2021·Granted Jul 1, 2025·0 cites·3 claims
- 3176US10421718B2EBNA1 inhibitors and their method of useWISTAR INST·Filed 2017·Granted Sep 24, 2019·1 cites·24 claims
- 3275US11912659B2EBNA1 inhibitors and methods using sameWISTAR INST·Filed 2021·Granted Feb 27, 2024·0 cites·10 claims
- 3375US5294648AAlkaline resol phenol-aldehyde resin binder compositionFOSECO INT·Filed 1993·Granted Mar 15, 1994·21 cites·14 claims
- 3470US12116359B2EBNA1 inhibitor crystalline forms, and methods of preparing and using sameTHE WISTAR INST·Filed 2022·Granted Oct 15, 2024·0 cites·10 claims
- 3568US12295942B2Riluzole prodrugs and their useBIOHAVEN THERAPEUTICS LTD·Filed 2021·Granted May 13, 2025·0 cites·5 claims
- 3668US2025332148A1Riluzole prodrugs and their useBIOHAVEN THERAPEUTICS LTD·Filed 2025·Application pending·0 cites
- 3764US9856214B2EBNA1 inhibitors and their method of useWISTAR INST·Filed 2014·Granted Jan 2, 2018·0 cites·8 claims
- 3863US11242338B2EBNA1 inhibitor crystalline forms, and methods of preparing and using sameTHE WISTAR INST·Filed 2019·Granted Feb 8, 2022·0 cites·25 claims
- 3963US5726171AN-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo B! 1,4!diazepin-3yl)-acetamidesMERCK & CO INC·Filed 1996·Granted Mar 10, 1998·20 cites·18 claims
- 4063US2021236470A1Prodrugs of riluzole and their method of useBIOHAVEN THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 4162US9193681B1Propionic acids, propionic acid esters, and related compoundsPROMENTIS PHARM INC·Filed 2014·Granted Nov 24, 2015·0 cites·9 claims
- 4259US5691332AN-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amidesMERCK & CO INC·Filed 1996·Granted Nov 25, 1997·15 cites·21 claims
- 4352US8853391B2Tricyclic azaindolesHUCK BAYARD R·Filed 2009·Granted Oct 7, 2014·0 cites·6 claims
- 4452US2024009122A1Small Molecule FormulationDIALECTIC THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4550US5242957AAlkaline resol phenol-aldehyde resin binder compositions containing phenyl ethylene glycol etherFOSECO INT·Filed 1992·Granted Sep 7, 1993·7 cites·9 claims
- 4650US5198478AAlkaline resol phenol-aldehyde resin binder compositionsFOSECO INT·Filed 1992·Granted Mar 30, 1993·7 cites·13 claims
- 4750US2022388962A1Molecules that bind to tdp-43 for the treatment of amyotrophic lateral sclerosis and related disordersBIOHAVEN THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 4850US2024018121A1Novel heteroaromatic compounds exhibiting antifungal activity and their method of useFOX CHASE CHEMCIAL DIVERSITY CENTER INC·Filed 2021·Application pending·0 cites
- 4942US5691331AN-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amidesMERCK & CO INC·Filed 1995·Granted Nov 25, 1997·4 cites·12 claims
- 5041US8609849B1Hydroxylated sulfamides exhibiting neuroprotective action and their method of useSMITH GARRY ROBERT·Filed 2011·Granted Dec 17, 2013·0 cites·15 claims
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Garry Robert Smith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →